Please read the below information thoroughly & carefully.
​
Only click agree if you fully understand the information. If you are unsure, please contact us via telephone (0330 311 0008) or email.
​
How the medication works:
​
The medications we provide all work in very similar ways. The major difference is that the weekly jab is a slow-release version of the daily jab & tablet.
Produced by Novo Nordisk, the medication mimics a natural hormone already found in your body (GLP-1). It works in three key ways to reduce your appetite.
-
It blocks a key hunger hormone telling your brain that you are hungry, whilst also helping to reduce leptin resistance (a hormone which can affect your metabolism & weight). This also helps stop the weight from coming straight back on when you stop the jab.
-
It slows down the gastric emptying process, meaning that your body takes longer to process food and it is fuller for longer. This means your body does not need as much intake as normal as it works off the food it has.
-
The medication helps to speed up your metabolism and increase fat burning by reducing glucagon & reducing insulin resistance. This promotes normal blood glucose levels, the liver metabolism of glucose and helps adipose tissue burn fat in a safe and controlled method without causing a sugar-crash. This avoids the urges for quick-fix sugary foods.
This all helps to reduce the risk of the so-called "starvation mode".
​
How to administer the medication:
​
We will send you an aftercare email which will have the full instructions on how to take the medication. The medication also comes with the manufacturer's Patient Information Leaflet which explains how to take the medication.
​
For the injections, we provide a demo video so that you can pause, rewind & re-watch the video in your own time at your own speed.
​
All of the literature and videos are also available on our online members area.
​
Licensing of the medication:
​
The daily injection (Saxenda) and weekly injection (Wegovy) are licensed for weight loss in the UK.
​
The weekly injections (Trulicity & Ozempic) and the daily tablet (Rybelsus) are not licensed for weight loss in the UK. Semaglutide (Ozempic/Rybelsus) has been licensed for weight loss in the UK under the brand name Wegovy.
​
It is safe & legal to prescribe a medication for a purpose other than it's current license - this is called off-label prescribing. You must be aware and fully informed of this, plus all the information regarding the medication (how it works, side effects etc) before being prescribed a medication off-label.
Side Effects:
​
Everyone is different. You may not experience any side effects, you may experience one side effect or several side effects.
The most common side effects associated with this medication are:
​
Nausea
Headaches
Dry Mouth
Constipation
Loose Stool
Tiredness
Stomach Cramps
​
We send aftercare literature to advice you on how to deal with these side effects should you experience them. Please do not hesitate to contact us if you need any support on dealing with side effects.
​
Adverse Effects:
​
Adverse effects are rare but they are something you should be aware of.
​
Adverse effects may include:
​
Palpitations / Fast Heart Rate
Pancreatitis
​
If you experience or feel that you may be experiencing these adverse effects, please stop using the medication & contact 111. When you are safe to do so, please contact us.
​
Anaphylaxis:
​
There have been no documented cases of an anaphylactic reaction to Liraglutide, Dulaglutide or Semaglutide but as this is a new medication being introduced to your body, we want to make you aware of the possible signs of anaphylaxis.
​
If you experience swelling of the lips/tongue/throat, difficulty breathing, tightness in the chest, a severe rash or severe itching, discontinue use immediately and call 999.
​
By confirming your order, you agree for us to contact you via email & telephone.
